Metabolic Explorer (METEX.PA) Stock Price

Metabolic Explorer Price

Delisted
0.12EUR
Last traded price

Over the last 18 years Metabolic Explorer grew revenue by 48.7% annually, reaching 226.60 M EUR. Earnings per share have grown at 24.5% per year over the last 15 years. For Metabolic Explorer, the net margin of -22.4% is up versus -185.5% a few years ago.

Metabolic Explorer stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Metabolic Explorer over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Metabolic Explorer stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Metabolic Explorer's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Metabolic Explorer Stock Price History
DateMetabolic Explorer Price
Access this data via the Eulerpool API

Metabolic Explorer Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
350,000.00 EUR
-8.38 M EUR
-8.25 M EUR
Jan 1, 2020
50,000.00 EUR
-9.65 M EUR
-8.93 M EUR
Jan 1, 2021
169.69 M EUR
73.04 M EUR
82.62 M EUR
Jan 1, 2022
226.60 M EUR
-43.76 M EUR
-50.83 M EUR
Jan 1, 2023 (e)
135.96 M EUR
-31.93 M EUR
-37.75 M EUR
Jan 1, 2024 (e)
198.79 M EUR
-10.30 M EUR
-17.95 M EUR
Jan 1, 2025 (e)
260.59 M EUR
7.21 M EUR
-4.14 M EUR
Jan 1, 2026 (e)
425.90 M EUR
32.16 M EUR
64.19 M EUR

Metabolic Explorer Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 31, 2026, 12:22 PM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
NET INCOME GROWTH%
SHARESM
2011201220132014201520162017201820192020202120222023e2024e2025e2026e
1.002.003.001.004.003.00169.00226.00135.00198.00260.00425.00
100.00300.00-25.0033.73-40.2746.6731.3163.46
-100.00-50.00-33.33-100.00-25.00-33.339.47-0.44-0.44-0.44-0.44-0.44
-1.00-1.00-1.00-1.00-1.00-1.00-1.00-1.00-1.00-1.0016.00-1.00-0.60-0.88-1.15-1.88
-5.00-7.00-4.00-3.00-6.0010.00-11.00-5.00-8.00-9.0073.00-43.00-31.00-10.007.0032.00
-500.00-350.00-100.001,000.00-275.00-166.6743.20-19.03-22.96-5.052.697.53
-3.00-8.00-3.00-3.00-7.006.00-11.00-6.00-8.00-8.0082.00-50.00-37.00-17.00-4.0064.00
50.00166.67-62.50133.33-185.71-283.33-45.4533.33-1,125.00-160.98-26.00-54.05-76.47-1,700.00
21.2222.2122.2322.2623.1628.0823.6223.8223.8227.8837.4544.6944.6944.6944.6944.69
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Metabolic Explorer generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Metabolic Explorer retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Metabolic Explorer's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Metabolic Explorer has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Metabolic Explorer's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Metabolic Explorer stock margins

The Metabolic Explorer margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Metabolic Explorer. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Metabolic Explorer.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
-0.63 %
-152.03 %
-185.49 %
Jan 1, 2019
-0.63 %
-2,393.43 %
-2,355.71 %
Jan 1, 2020
-3,324.00 %
-19,304.00 %
-17,864.00 %
Jan 1, 2021
9.44 %
43.04 %
48.69 %
Jan 1, 2022
-0.63 %
-19.31 %
-22.43 %
Jan 1, 2023 (e)
-0.63 %
-23.48 %
-27.76 %
Jan 1, 2024 (e)
-0.63 %
-5.18 %
-9.03 %
Jan 1, 2025 (e)
-0.63 %
2.77 %
-1.59 %

Metabolic Explorer Stock Revenue, EBIT, Earnings per Share

The Metabolic Explorer earnings per share therefore indicates how much revenue Metabolic Explorer has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.14 EUR
-0.21 EUR
-0.26 EUR
Jan 1, 2019
0.01 EUR
-0.35 EUR
-0.35 EUR
Jan 1, 2020
0.00 EUR
-0.35 EUR
-0.32 EUR
Jan 1, 2021
4.53 EUR
1.95 EUR
2.21 EUR
Jan 1, 2022
5.07 EUR
-0.98 EUR
-1.14 EUR
Jan 1, 2023 (e)
3.04 EUR
-0.71 EUR
-0.84 EUR
Jan 1, 2024 (e)
4.45 EUR
-0.23 EUR
-0.40 EUR
Jan 1, 2025 (e)
5.83 EUR
0.16 EUR
-0.09 EUR

Metabolic Explorer business model & stock analysis

Metabolic Explorer SA is a French biotechnology company that was founded in 1999. It is headquartered in Clermont-Ferrand, France and employs approximately 70 employees, including scientists and engineers. The company specializes in the development and production of natural raw materials that are used in various industries such as cosmetics, food, and pharmaceuticals. The business model of Metabolic Explorer is based on innovative biological technology that enables the production of novel bio-based molecules by optimizing the metabolic processes of microorganisms. These novel molecules have higher quality and efficiency than conventional raw materials, making them promising alternatives for various industries. The company has specialized in various business areas. One of the most important is the production of bio-based amino acids used in the cosmetics and food industries. Metabolic Explorer has developed a patented method for producing amino acids from renewable resources such as plants and bacteria. This allows for amino acids to be produced without the use of petrochemical raw materials, making them more environmentally friendly and sustainable alternatives. Another business area of Metabolic Explorer is the production of bio-based lactic acid. Lactic acid is an important raw material for the production of bio-polymers, such as PLA (polylactic acid), used in the packaging industry. Again, Metabolic Explorer has developed a patented technology for producing lactic acid from renewable resources. Metabolic Explorer is also involved in the research and development of bio-molecules. The company works closely with various research institutions to optimize its biological technologies and processes and develop new applications. The goal is to improve the production of bio-based molecules and reduce costs. An example of Metabolic Explorer's innovative products is bio-based nylon precursor. Nylon is typically produced from petrochemical raw materials, leading to high costs and environmental impact. However, Metabolic Explorer has developed a patented technology that allows for the production of bio-based precursors that can be used as raw materials for nylon production. These bio-based precursors are made from renewable resources and can enable a more environmentally friendly and sustainable nylon. Metabolic Explorer has a variety of partnerships and collaborations with companies in various industries. One example is the collaboration with food company Roquette to develop bio-based glycerin products. Another partnership is with cosmetics company L'Oréal to develop bio-based lactic acid for use in cosmetics. Overall, Metabolic Explorer specializes in the development and production of bio-based molecules that offer a promising alternative to conventional petrochemical raw materials. With its patented biological technologies, the company is well-positioned to make a significant contribution to sustainability in various industries.

Metabolic Explorer SWOT Analysis

Strengths

Metabolic Explorer SA has several strengths that contribute to its success in the market. Firstly, the company possesses innovative and proprietary technologies for producing sustainable chemicals. This gives them a competitive edge and enables them to offer unique value to their customers. Additionally, their strategic partnerships with key players in the industry strengthen their market position and provide access to necessary resources. Moreover, their strong research and development capabilities help them in continuously improving their products and staying at the forefront of innovation.

Weaknesses

Despite their strengths, Metabolic Explorer SA faces certain weaknesses that need to be addressed. One of the major weaknesses is their dependency on a limited range of products, which makes them vulnerable to market fluctuations and changing customer demands. Furthermore, their relatively small scale of operations may hinder their ability to compete with larger, more established companies in terms of production capacity and market reach. It is important for the company to diversify their product portfolio and expand their operations to mitigate these weaknesses.

Opportunities

Metabolic Explorer SA operates in an industry with significant growth potential, which presents various opportunities for expansion. The increasing demand for sustainable chemicals and the shift towards a circular economy create a favorable market environment for the company. They can leverage their technology and expertise to capitalize on this growing demand and gain a larger market share. Furthermore, the global focus on reducing carbon emissions provides an opportunity for Metabolic Explorer SA to position themselves as a leader in providing eco-friendly solutions.

Threats

Despite the opportunities, Metabolic Explorer SA also faces certain threats that could impact their business. One of the major threats is the presence of strong competitors in the market who offer similar products and technologies. This heightens the competition and puts pressure on pricing and market share. Additionally, the regulatory environment and government policies regarding sustainability and chemical production can impact the company's operations and profitability. It is crucial for Metabolic Explorer SA to stay updated with changing regulations and adapt their strategies accordingly.

Metabolic Explorer Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Metabolic Explorer historical P/E ratio, EBIT multiple, and P/S ratio

Metabolic Explorer annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Metabolic Explorer shares outstanding

The number of shares of Metabolic Explorer was 44.69 M in 2025. This indicates how many shares Metabolic Explorer is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
23.82 M Stocks
Jan 1, 2019
23.82 M Stocks
Jan 1, 2020
27.88 M Stocks
Jan 1, 2021
37.45 M Stocks
Jan 1, 2022
44.69 M Stocks
Jan 1, 2023 (e)
44.69 M Stocks
Jan 1, 2024 (e)
44.69 M Stocks
Jan 1, 2025 (e)
44.69 M Stocks
Price targets and forecasts for Metabolic Explorer are not yet available.

Metabolic Explorer shareholder structure

% Name
35.36837%
Bpifrance Investissement
Bpifrance Investissement
1.10483%
Edmond de Rothschild Asset Management (France) S.A.
Edmond de Rothschild Asset Management (France) S.A.
0.30780%
HSBC Global Asset Management (France) S.A.
HSBC Global Asset Management (France) S.A.
0.10069%
ACA Asset management Company & Associ¿s
ACA Asset management Company & Associ¿s
0.01105%
Edmond De Rothschild Asset Management (Luxembourg)
Edmond De Rothschild Asset Management (Luxembourg)
0.00000%
Mirova
Mirova

Metabolic Explorer Executives and Management Board

BG

Dr. Benjamin Gonzalez

(53)

Chairman of the Board, Chief Executive Officer · since 2007

Compensation369,207.00 EUR
DC

Mr. Daniel Cheron

(72)

Independent Director

Compensation60,000.00 EUR
JD

Mr. Jerome Dupas

(62)

Independent Director · since 2009

Compensation55,000.00 EUR
LB

Mr. Laurent Bastian

(55)

Finance Director, Support and Development

LC

Ms. Laurence Caron

Director of Human Resources

Metabolic Explorer Supply Chain

Metabolic Explorer Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
2 companies
#Name1M3M6M1Y2YTrend
1
UPM-Kymmene
Supplier
0.38
0.74
0.81
0.23
0.83
2
Koninklijke DSM
Supplier
-0.60
0.22
0.73
0.58
0.78

Frequently asked questions about Metabolic Explorer

The business model of Metabolic Explorer SA revolves around developing and commercializing sustainable biochemicals for various industries. With a focus on the production of organic acids, the company utilizes its proprietary technologies to transform renewable resources into high-value products. By leveraging their expertise in metabolic engineering and bioprocess optimization, Metabolic Explorer aims to provide cost-effective and eco-friendly alternatives to petrochemical-based products. Through strategic collaborations and licensing agreements, the company aims to expand its market presence and drive growth in the bioplastics, textiles, and animal nutrition sectors, contributing to a more sustainable and environmentally conscious future.

All fundamentals and in-depth analysis of Metabolic Explorer

Our stock analysis for Metabolic Explorer stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Metabolic Explorer. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.